Amy Walker

Amy Walker is an accomplished professional with extensive experience in the biotechnology sector. Currently serving as Chief Operating Officer at 4basebio since November 2020, Amy has also held the positions of Vice President of Research and Business Development, Director of Discovery, and Head of Discovery within the same company. Prior to 4basebio, Amy was a Post Doctoral Researcher at University College London from November 2019 to November 2020. Amy Walker holds a Doctor of Philosophy (PhD) in Gene Editing for Cystic Fibrosis from University College London, as well as a Master of Research in Biomedical Science and Translational Medicine, and a Bachelor of Science with Honours in Pharmacology, both from the University of Liverpool.